IL17A and arthritic joint disease: Neutralization of either IL-6 signaling by sgp130 [32] or IL-17A signaling by anti-IL-17 antibody [33] reduced pain-related behaviors in arthritis models, and IL-17A knockout mice showed significantly less mechanical hyperalgesia than wild-type mice in antigen-induced arthritis despite similar levels of inflammation [34].